Outpatient parenteral antimicrobial therapy (OPAT) offers benefits for patients as well as providing cost effectiveness; however, it is not without its challenges. Two clinicians provide insights on this modality.
Ryan Mynatt, PharmD, BCPS
Advertisement
Ryan Mynatt, PharmD, BCPS, is a clinical pharmacist specialist in Outpatient Parenteral Antimicrobial Therapy and Infectious Diseases at University of Kentucky HealthCare.
Articles by Ryan Mynatt, PharmD, BCPS
Advertisement
Latest Updated Articles
Tricky Infusion Issues and Potential Solutions: OPAT EditionPublished: May 4th 2023 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Is 4 Weeks of Glecaprevir/Pibrentasvir Sufficient to Treat Early Hepatitis C Infection?
2
Antibiotic Shows Promise in Treating Gram-Positive Pneumonia, Including in High-Risk Patients
3
Vaccines as a Secondary Strategy in the Fight Against Antimicrobial Resistance
4
